Halder Venture Approves Auditor Changes, Capital Increase, and Warrant Issue
Halder Venture's board approved auditor changes, appointing M/s J Kumar Jain & Associates. They also approved increasing authorized share capital to ₹18.42 crore and issuing 7,93,650 convertible warrants at ₹315 each to P.K. Bio Link Private Limited for approximately ₹24.99 crore. Shareholder approval via postal ballot is required for capital increase and warrant issuance.
The changes in auditors are routine. The increase in authorized capital and the issuance of warrants are significant corporate actions that could impact the company's capital structure and financial health, potentially leading to improved liquidity or expansion capabilities.
The company is taking proactive steps in auditor appointments, increasing its authorized capital, and planning to raise funds through convertible warrants, which are generally viewed positively as they can strengthen the company's financial position.
Halder Venture Limited's Board of Directors convened on March 26, 2026, approving several key resolutions. The board accepted the resignation of M/s Somnath Ray & Associates as Internal Auditor due to preoccupation and appointed M/s J Kumar Jain & Associates as the new Internal Auditor for the Financial Year 2025-2026. This appointment is subject to remuneration fixed by the Board.
Furthermore, the company resolved to increase its authorized share capital from ₹13.42 crore to ₹18.42 crore, creating an additional 50,00,000 equity shares of ₹10 each. This change in the Memorandum of Association is contingent upon shareholder approval via postal ballot.
In a significant move, the board also approved the creation, issue, and offer of 7,93,650 convertible warrants, each with a face value of ₹10 and an issue price of ₹315 (including a premium of ₹305). These warrants are convertible into one fully paid-up equity share each and will be issued to specified persons, including P.K. Bio Link Private Limited, as part of a preferential allotment. The total amount for this issuance is approximately ₹24.99 crore. The approval for the warrant issuance is also subject to shareholder consent through a postal ballot. The company will also seek shareholder consent via a postal ballot for these resolutions.
What to do with a filing like this
Halder Venture Limited filed this with the NSE as a statutory disclosure, categorised under auditor changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Halder Venture Limited. Read the original for the full detail.